Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor Plus G-CSF for Stem Cell Mobilization in NHL
NCT00103610Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of plerixafor in Non-Hodgkin lymphoma (NHL), sponsored by Sanofi. Started Jan 2005; status: completed.
02
Drugs
plerixafor
03
Conditions
Non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00103610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103610.